drugset / Trial / NCT03658655

Stem Cells From Human Exfoliated Teeth in Treatment of Type 2 Diabetes

NCT03658655 ↗

Phase 0 Completed 24 enrolled CAR-T (Shanghai) Biotechnology Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the safety and efficacy of Stem Cells From Human Exfoliated Teethtransplantation in patients with type 2 diabetes to provides scientific basis for further clinical studies to verify the safety and efficacy of type 2 diabetes.On the basis of maintaining the original treatment, intravenous drip of Stem Cells From Human Exfoliated Teeth.

Timeline

Start
2018-06-01
Primary completion
2019-11-10
Completion
2019-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Stem Cells From Human Exfoliated Teeth Cell therapy 0.1 iu/kg Intravenous